Abstract: A pharmaceutical composition comprises nanoparticles comprising a poorly water-soluble drug, a poorly aqueous soluble non-ionizable cellulosic polymer, and a poorly aqueous soluble polymeric amphiphilic non-ionizable block copolymer.

Abstract: The present disclosure relates to devices, methods and kits for accelerating the rate of whitening of teeth using an oxidizing agent, a photocatalytic agent, and a portable lightsource.

Abstract: Representative implementations of devices and techniques provide adjustable parameters for imaging devices and systems. Dynamic adjustments to one or more parameters of an imaging component may be performed based on changes to the relative velocity of the imaging component or to the proximity of an object to the imaging component.

Abstract: The present invention relates to the use of a combination of a certain DPP-4 inhibitor and an alpha-glucosidase inhibitor for use in therapy, e.g. for use in treating and/or preventing a metabolic disease such as type 2 diabetes mellitus and/or conditions related thereto. The invention also relates to the use of such combination for improving body weight control, reducing body weight, inducing satiety, inhibiting gastric emptying and/or reducing food intake, in a patient in need thereof.

Abstract: Example methods and apparatus to display mobile device contexts are disclosed. An example method includes displaying a first context in a user interface of a mobile device based on first device platform information, the first context including a first arrangement of information, graphics, and application icons that are associated with the first device platform information, determining that second device platform information received after the first device platform information corresponds to a second context, the second context being different from the first context and including a second arrangement of information, graphics, and applications that are associated with the second device platform information, and displaying the second context in the user interface replacing the first context without prompting a user of the mobile device.

Abstract: A connector includes a cable tray configured to receive and retain a cable in a stable position and couple with a top cap configured to create an electrical connection with the cable as the top cap is manipulated in a predetermined manner while coupled with the cable tray. An upper surface of the cable tray is configured to receive the cable. The cable tray also includes a finger extending beyond the first end for some distance longitudinally. The finger includes a protrusion that protrudes to some extent in a transverse direction so that a cable-accommodating gap is defined between the protrusion and the first end. The protrusion is configured to bear against the cable and retain the cable in the stable position when the cable is inserted between the protrusion and the first end (before, during and/or after an electrical connection is established).

Abstract: Some aspects of the present disclosure provide system and method of operation of a driving circuit for a light emitting element in a Time-of-Flight (ToF) camera. A DC-DC converter is configured to emit a constant current, and is coupled in parallel to a first modulation switch configured to connect the driving circuit to ground. The first modulation switch is further configured to alternate connections between the current source and ground at a frequency in a desired range of operation to produce an AC current. In some embodiments, an RC circuit element is coupled to an output electrode of the light emitting element and configured to apply a reverse bias to decrease turn-off time of the light emitting element. In some embodiments, a second modulation switch is coupled to the output electrode and configured to apply the reverse bias across the light emitting element. Other systems and methods are also disclosed.

Abstract: A device is provided for hanging a frame member against a wall includes a crossbar and first and second vertical arms oriented perpendicular to the crossbar. The crossbar has a longitudinal track and a leveling bubble. The first and second vertical arms each have a linear track that extends along the length, and a marker on the rearward surface thereof. The vertical arms are retained to the crossbar by knuckles having a guide for slideably engaging the linear track of the vertical arms and the first vertical arms are retained perpendicular to the crossbar and are longitudinally moveable perpendicular to the linear edge.

Abstract: A housing for enclosing electronics of a motor having an axis of rotation is provided. The housing includes an end cap having an outer surface and an inner surface. A control board is coupled to the inner surface, wherein the printed circuit board includes a first side, a second side and an edge located between the first side and the second side. The housing further includes a first circuit coupled to the first side which includes a plurality of first electrical components. Each first electrical component includes a tab extending beyond the edge. A second circuit is coupled to the second side and a fastener assembly is coupled to the tab and the inner surface.

Abstract: The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor and an insulin which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia.

Abstract: A pharmaceutical composition includes 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(R)-amino-piperidin-1-yl]-xanthine or a pharmaceutically acceptable form thereof as pharmaceutically active compound for the therapy of a metabolic disorder or metabolic disease of a predominantly carnivorous non-human animal. It is especially useful for the therapy of diabetes and related diseases of predominantly carnivorous mammals like cats or dogs. The invention further provides respective uses of such compositions and of 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(R)-amino-piperidin-1-yl]-xanthine or pharmaceutically acceptable forms thereof.

Abstract: The present invention is directed to the automatic configuration of portal composite applications.

Abstract: A housing for coupling to a motor having an axis of rotation is provided. The housing includes an end cap having an outer surface and an inner surface. The housing also includes a plurality of first heat fins coupled to the outer surface. Each first heat fin of the plurality of first heat fins includes a first portion extending radially from the axis of rotation. In addition, the housing includes a second portion coupled to first portion and extending parallel to the axis of rotation. The housing further includes a second heat fin coupled to the second portion.

Abstract: Program optimization systems are provided herein. The program optimization system can include a plurality of data sources that can be mined for information relating to one or several patients. The format and content of the information from the data sources can be evaluated and can be conformed to formats and content types used by the program optimization system. The information retrieved from the data sources can be evaluated for one or several trigger events. If a trigger event is identified in the retrieved data, a treatment protocol can be selected.

Abstract: A hair treatment formulation comprises a plurality of composite nanoparticles in solution. The composite nanoparticles are specifically prepared having an inner core, comprising at least one protein, an intermediate starch-thiolate layer, and an outer layer comprising chitosan or modified chitosan. At least one treatment component is embedded in at least one of the inner core, intermediate layer, or outer layer. A method of preparing a hair treatment formulation comprising composite nanoparticles is disclosed along with a method of use of a hair treatment formulation comprising a plurality of composite nanoparticles.

Abstract: Systems and methods are provided for providing and displaying enhanced banners and other objects on a communication device. The banner file may comprise ancillary data, such as calendar appointment details, other event details, or contact details, embedded within the file itself, or comprised in an envelope wrapping the banner file. When the banner is displayed on the communication device, the user may invoke a context menu to create an event, such as a calendar event, on the device using the embedded ancillary data. In other embodiments, the communication device uses geolocation services to determine whether the user is likely to be in attendance at an event, and if not, to issue alerts or initiate a further action, such as initiating recording of a television program the user is about to miss, over the network. In other embodiments, the banner file's ancillary data includes recommendation data, identifying a banner as being recommended by a contact of the user's.

Abstract: A variable gravity training device allows a user to train skills in controlling a sports device. The training device has a stationary base, a movable support bar, and a sports device, for example, a ball, a badminton birdie, or a volley ball affixed to the end of the bar. The support bar is weighted, so that the amount of force required to move the sports device is reduced. The weighted bar also reduces the speed with which the sports device returns to its home position. The force adjustment means is adjustable, so that, with training, weights may be removed, so that the conditions governing the sports device correspond to real playing conditions.

Abstract: Representative implementations of devices and techniques provide adaptable settings for imaging devices and systems. Operating modes may be defined based on whether movement is detected within a predetermined area. One or more parameters of illumination or modulation may be dynamically adjusted based on the present operating mode.

Abstract: The specification describes the use of selected DPP IV inhibitors for the treatment of physiological functional disorders and for reducing the risk of the occurrence of such functional disorders in at-risk patient groups. In addition, the use of the above-mentioned DPP IV inhibitors in conjunction with other active substances is described, by means of which improved treatment outcomes can be achieved. These applications may be used to prepare corresponding medicaments.